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Introduction
Over the last decades MRI has proved to be very useful in
the field of drug development and discovery. Pharmaco-
logical MRI (phMRI) explores the interaction between
brain physiology, neuronal activity and drugs[1]. The
BOLD-signal is an indirect method to investigate brain
activity by way of measuring task-related hemodynamic
changes. Pharmacological substances that induce hemo-
dynamic changes can therefore potentially alter the
BOLD-signal that in turn falsely can be interpreted as
changes in neuronal activity. It is therefore important to
characterize possible effects of a pharmacological
substance on the BOLD-response per see before that
substance can be used in an fMRI experiment. Further-
more MR-angiography is useful in determining the
vascular site-of-action of vasoactive substances.
Methods
Four substances; Acetazolamide, Glyceryl Trinitrate
(GTN), CGRP and sumatriptan has been examined
using a 3-Tesla MRI scanner in three double-blind pla-
cebo-controlled crossover studies in normal volunteers.
Results
Acetazolamide depresses the BOLD-signal by increasing
cerebral blood flow (CBF). GTN had surprisingly no effect
on the BOLD-signal even though it is known to increase
cerebral blood volume (CBV)[2]. Infusion of CGRP
induces immediate headache and dilates the middle
meningeal artery (MMA) but contrarily to previous belief
does not dilate the middle cerebral artery (MCA)[3]. Nor
does CGRP increase brain activity per see[4]. Sumatriptan
ameliorates headache, contracts MMA and marginally
constricts MCA[3] without altering brain activity[4].
Conclusion
Acetazolamide depresses the BOLD-signal while GTN
does not alter the BOLD-signal. Neither CGRP or suma-
triptan has a direct effects on brain activity. Instead it
seems that both the migraine provoking peptide CGRP
and the anti-migraine drug sumatriptan exert their
actions outside of the blood brain barrier. These studies
show that phMRI can be a powerful tool in understand-
ing mechanisms and site-of-action of pharmacological
compounds. And can have important implication for
implementation of fMRI in headache research.
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